CN1133445C - Jianfuling medicine for skin disease and its compounding process - Google Patents

Jianfuling medicine for skin disease and its compounding process Download PDF

Info

Publication number
CN1133445C
CN1133445C CNB001328395A CN00132839A CN1133445C CN 1133445 C CN1133445 C CN 1133445C CN B001328395 A CNB001328395 A CN B001328395A CN 00132839 A CN00132839 A CN 00132839A CN 1133445 C CN1133445 C CN 1133445C
Authority
CN
China
Prior art keywords
medicine
externally
present
used medicine
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB001328395A
Other languages
Chinese (zh)
Other versions
CN1294920A (en
Inventor
彪 曾
曾彪
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB001328395A priority Critical patent/CN1133445C/en
Publication of CN1294920A publication Critical patent/CN1294920A/en
Application granted granted Critical
Publication of CN1133445C publication Critical patent/CN1133445C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

The present invention belongs to an externally-used medicine for treating dermatosis, which is prepared from Chinese medicines and western medicines. The externally-used medicine comprises the components of Chinese pyrola herb phenol, menthol, camphor, resorcinol, salicylic acid and dragon blood. The present invention uses liquefied liquid obtained by a melting method as solvents, and no cosolvent is added during the preparing process. The externally-used medicine has the advantages of obvious therapeutic effect, quick fungus killing, strong medicine penetrability and no toxicity. The present invention can kill fungi on the shallow surface of skin and fungi at the deep parts of affected regions, and can also form a medicinal film layer on the skin. Thus, the present invention can protect the skin and persistently and slowly take effect in the affected regions for a long time. The affected regions can be cured after the externally-used medicine is smeared for two to three times. The externally-used medicine has a special good effect on psoriasis and neurodermatitis.

Description

The medicine for external use and the compound method thereof of treatment neurodermatitis, intractable tinea
The present invention relates to a kind of medicine for external use and compound method thereof by the formulated treatment tinea of multiple Chinese medicine and western medicine.Tinea is a commonly encountered diseases, and sickness rate is higher, and the patient has a strong impact on people's work, studying and living because of skin pruritus.Treat the employed various medicines of tinea at present, drug effect is had nothing in common with each other, but is difficult to radical cure, can only take stopgap measures, and mitigate the disease can not be removed patient's misery.
The present invention's bonded way of Chinese medicine and western medicine, adopt multiple Chinese medicine and western medicine preparation, with the fusion method liquefier is solvent, do not add cosolvent in the preparation to improve drug level and viscosity, reduce volatility and mobile, improve drug penetration and drug effect, make and kill fungus at short notice, reach and cure tinea, the particularly purpose of refractory skin such as neurodermatitis and psoriasis.
The objective of the invention is to realize by following approach.It is formulated with multiple Chinese medicine and western medicine, contains thymol, Mentholum, Camphora, resorcinol, salicylic acid and Sanguis Draxonis in the batching, and the parts by weight of batching are respectively thymol 5-15, Mentholum 15-25, Camphora 15-25, resorcinol 5-35, salicylic acid 40-90, Sanguis Draxonis 15-25.
Compound method of the present invention is: utilizing the interaction of medicine, is solvent with the fusion method liquefier, does not add cosolvent in the preparation, adds in batches, fully grinds to form.Sanguis Draxonis is ground into fine powder earlier during preparation, and soaks the back reuse with dimethyl sulfoxide or anhydrous alcohol.During preparation, earlier place container to grind a little thymol and Mentholum, camphorate and be ground into colourless transparent liquid, as solvent, the resorcinol with porphyrize adds in the liquid several times again, fully grinds, jolting makes it dissolving, at last salicylic acid and fine powder of dragons blood adding are several times successively gone up in the liquid,, made it to become kermesinus like paste with adding with grinding.
The present invention adopts multiple Chinese medicine and western medicine preparation, effect is remarkable, embrocates the affected part, can kill fungus at short notice, through detecting by Disinfection Effect among the GB5981-1995: ATCC (10231) bacterial strain killing rate in 10 minutes is that killing rate is 100% in 99,99%, 30 minutes.Drug penetration is strong, not only can kill skin superficial fungi, and can kill affected part depths fungus.The strong adhesion of medicine can form one deck medicine film on skin, not only can protect skin, and can be for a long time continues in the affected part and bring into play drug effect lentamente.The avirulence side effect is little, only needs embrocate once in 10 days, embrocates once and takes a turn for the better, and embrocates two to three times and can cure.Psoriasis and neurodermatitis there is specially good effect.
The present invention is described in further detail in conjunction with the embodiments.
Embodiment 1: get thymol 10 grams, Mentholum 20 grams place container to grind a little, get Camphora 20 grams again and add common the grinding, make it to become colourless transparent liquid, as solvent, get resorcinol 10 gram porphyrizes again, add several times and go up in the liquid, fully grind, jolting makes it dissolving, get salicylic acid 50 gram and fine powder of dragons blood 20 grams then and successively add several times and go up in the liquid, with adding with grinding, make it to become kermesinus seemingly pasty state get final product.
Embodiment 2: get thymol 10 grams, Mentholum 20 grams place container to grind a little, get Camphora 30 grams again and add common the grinding, make it to become colourless transparent liquid as solvent, get resorcinol 30 gram porphyrizes again, add several times and go up in the liquid, fully grind, jolting makes it dissolving, the fine powder of dragons blood 20 of getting salicylic acid 80 grams then and soaking more than 48 hours with dimethyl sulfoxide or 95% ethanol restrains, successively add several times and go up in the liquid,, make it to become kermesinus and get final product like pasty state with adding with grinding.
Model case:
Section certain, Lengshuijiang City steel general factory workman, the man, 30 years old, cervical region symmetry neurodermatitis was made a definite diagnosis and is treated through higher level hospital and do not heal, and embrocates medicine for external use of the present invention 4 times, cured in about 30 days.
Gold certain, the cadre of Lengshuijiang City government, the man, 50 years old, ancon was diagnosed as neurodermatitis through how tame hospitals such as No.2 Hospital Attached to Hunan Medical University, obstinate is embrocated the i.e. healing of the present invention 4 times.
The week certain, certain school student is the No.2 Hospital Attached to Hunan Medical University family members, the woman, 12 years old, six months right crus of diaphragm back ofs the body of being born were from the beginning of grand spotting out, pale red, secondary generate piece is very itched, never take off socks, Annex II is diagnosed as psoriasis, and it is effective to embrocate certain hospital's self-control tinea liquid, but does not heal, and can not drug withdrawal, drug withdrawal is promptly sent out.Being coated with medicine for external use of the present invention promptly heals for 3 times.
The Shen, the cadre of Zhuzhou Physical Culture and Sports Commission, the man, 43 years old, the left foot back of the body was diagnosed as psoriasis through Affiliated Hospital of Hunan Medical University and Affiliated Hospital of Beijing Medical University, and obstinate is embrocated medicine for external use of the present invention and is promptly healed for 3 times.
Tan, retired employees of Tin Mine Mining Affairs Bureau, the man, 60 years old, right cervical region was suffered from neurodermatitis, does not heal through how tame large hospital diagnosis and treatment, embrocates medicine for external use of the present invention and promptly heals for 2 times.
Using method:
1, medicine for external use of the present invention is solid, semisolid or liquid because of temperature difference in season, can use behind the jolting mixing of need heating before using.
2, applying medicinal lotion or ointment preceding affected part need be dry, and epidermis does not have breakage, needs use after the antiinflammatory if any inflammation, and there is slight gargalesthesia in about 40 minutes affected parts behind the coating, must guard against scabies and grab, and cause infection in order to avoid scratch skin.Coating decrustation after 5 days can not be cleaned the affected part before the decrustation, 8-10 day the same method again coating once can cure for 2-4 time.

Claims (2)

1. external used medicine for the treatment of neurodermatitis, intractable tinea, it is characterized in that: it is made up of following various medicaments in part by weight, be respectively thymol 5-15, Mentholum 15-25, Camphora 15-25, resorcinol 5-35, salicylic acid 40-90, Sanguis Draxonis 15-25.
2. the compound method of the described medicine of claim 1: place container to grind to form colourless transparent liquid a little thymol and Mentholum earlier, as solvent, resorcinol with porphyrize adds fully grinding in the aforesaid liquid several times again, jolting makes it dissolving, at last salicylic acid and fine powder of dragons blood adding are several times successively gone up in the liquid, with adding, make it to become kermesinus like paste with grinding.
CNB001328395A 2000-11-03 2000-11-03 Jianfuling medicine for skin disease and its compounding process Expired - Fee Related CN1133445C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB001328395A CN1133445C (en) 2000-11-03 2000-11-03 Jianfuling medicine for skin disease and its compounding process

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB001328395A CN1133445C (en) 2000-11-03 2000-11-03 Jianfuling medicine for skin disease and its compounding process

Publications (2)

Publication Number Publication Date
CN1294920A CN1294920A (en) 2001-05-16
CN1133445C true CN1133445C (en) 2004-01-07

Family

ID=4595419

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB001328395A Expired - Fee Related CN1133445C (en) 2000-11-03 2000-11-03 Jianfuling medicine for skin disease and its compounding process

Country Status (1)

Country Link
CN (1) CN1133445C (en)

Also Published As

Publication number Publication date
CN1294920A (en) 2001-05-16

Similar Documents

Publication Publication Date Title
CN105142728B (en) Compositions and methods for treating surface wounds
US9125964B2 (en) Pharmaceutical composition and device for preventing, treating and curing ulcers on a diabetic foot and other wounds, which includes snail slime from the species Cryptophalus aspersus or Helix aspersa muller and pharmaceutically acceptable carriers and/or additives
Rivera-Arce et al. Therapeutic effectiveness of a Mimosa tenuiflora cortex extract in venous leg ulceration treatment
JP2019517533A (en) External pharmaceutical composition for treatment of various wound wounds of skin and preparation method thereof
CN102159198A (en) Topical treatment of skin infection
CN104666496B (en) A kind of menthol ointment and its preparation technology
CN106552062A (en) A kind for the treatment of beri-beri agent
CN102283899B (en) Traditional Chinese medicine external preparation and application thereof
CN1052881C (en) Burn and scald ointment
CN1133445C (en) Jianfuling medicine for skin disease and its compounding process
EP3369428A1 (en) External traditional chinese medicine preparation for diminishing inflammation, relieving pain and promoting fast healing, and preparation method therefor
CN110974861A (en) Blumea balsamifera oil liposome
CN110013502A (en) A kind of composition for preventing and treating acute and chronic rhinitis, nasosinusitis
CN105287742A (en) Ointment capable of controlling mosquito bite and preparation method thereof
CN101361938A (en) Kibe paste containing natural zingiber oil
CN1903214B (en) Ointment containing red precipitate
CN108392515A (en) A kind of tinea of feet and hands treatment liquid
CN108635362A (en) A kind of pharmaceutical composition for treating diabetes
CN1989976A (en) Effective therapeutic agent for ringworm of the nails
CN1989950A (en) Sterilizing effective antipruritic application agent
CN108853300A (en) It is a kind of for arthralgia and myalgia and the exterior-applied medical wine of bacterio static itching-relieving
CN102670689A (en) Method for preparing spray for curing psoriasis
WO2018188197A1 (en) Antibacterial and anti-inflammatory drug and preparation method therefor
CN114209751A (en) Liquid dressing for treating onychomycosis and preparation method thereof
CN111450128A (en) Medicine for treating beriberi

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee